Edition:
United Kingdom

People: Amarin Corporation PLC (AMRN.OQ)

AMRN.OQ on NASDAQ Stock Exchange Global Market

17.25USD
16 Sep 2019
Change (% chg)

$0.54 (+3.23%)
Prev Close
$16.71
Open
$16.68
Day's High
$17.27
Day's Low
$16.68
Volume
1,044,303
Avg. Vol
1,813,049
52-wk High
$23.91
52-wk Low
$2.66

Kalb, Michael 

Mr. Michael Wayne Kalb, CPA is the Chief Financial Officer, Senior Vice President, Assistant Secretary of the Company. He joined Amarin in June 2016 as Senior Vice President and Chief Financial Officer. Mr. Kalb served as Group Vice President, Chief Financial Officer and Chief Accounting Officer of Taro Pharmaceutical Industries Ltd. from August 2014 to June 2016. Prior to that, Mr. Kalb was GVP, Interim CFO and CAO from November 2010 to August 2014 and GVP, Chief Financial Officer—U.S. and CAO from May 2010 to November 2010. Mr. Kalb joined Taro in June 2009 as VP, Chief Financial Officer—U.S. He has over 20 years of financial and accounting advisory experience. From June 2004 to June 2009, Mr. Kalb served as a Director in the Accounting and Financial Consulting Group of Huron Consulting Group Inc. His experience also includes over ten years at Ernst & Young, LLP within the Transaction Advisory Services Group and Audit and Assurance Services Group. Mr. Kalb received a B.S. in Accounting from the University at Albany, State University of New York. Mr. Kalb is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, USD 669,519
Restricted Stock Award, USD 296,400
Long-Term Incentive Plans, USD --
All Other, USD 301,500
Fiscal Year Total, USD 1,267,420

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Lars Ekman

--

John Thero

4,205,780

Michael Kalb

1,267,420

Joseph Kennedy

1,363,330

Stephen Ketchum

1,329,520

Aaron Berg

--
As Of  31 Dec 2018